| Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers (NCT01846520) | City of Hope Medical Center | 2013-10-01 |
| Pazopanib in Treating Patients With Metastatic Urothelial Cancer (NCT00471536) | National Cancer Institute (NCI) | 2008-08-01 |
| Gemcitabine, Paclitaxel, Doxorubicin in Metastatic or Unresectable Bladder Cancer With Decreased Kidney Function (NCT00478361) | M.D. Anderson Cancer Center | 2007-04-01 |
| VEGF Trap in Treating Patients With Recurrent, Locally Advanced, or Metastatic Cancer of the Urothelium (NCT00407485) | National Cancer Institute (NCI) | 2006-11-01 |
| Vorinostat in Treating Patients With Locally Recurrent or Metastatic Cancer of the Urothelium (NCT00363883) | National Cancer Institute (NCI) | 2006-06-01 |
| Sorafenib in Treating Patients With Regional or Metastatic Cancer of the Urothelium (NCT00112905) | National Cancer Institute (NCI) | 2005-10-01 |
| Sorafenib in Treating Patients With Advanced or Metastatic Cancer of the Urinary Tract (NCT00112671) | National Cancer Institute (NCI) | 2005-04-01 |
| Phase II Trial Of PS-341 (Bortezomib) In Patients With Previously Treated Advanced Urothelial Tract Transitional Cell Carcinoma (NCT00072150) | National Cancer Institute (NCI) | 2003-10-01 |
| Trastuzumab in Treating Patients With Previously Treated, Locally Advanced, or Metastatic Cancer of the Urothelium (NCT00004856) | National Cancer Institute (NCI) | 2002-07-01 |
| Gefitinib Plus Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Bladder Cancer (NCT00041106) | National Cancer Institute (NCI) | 2002-05-01 |
| Ixabepilone in Treating Patients With Advanced Urinary Tract Cancer (NCT00021099) | National Cancer Institute (NCI) | 2001-06-01 |
| Arsenic Trioxide in Treating Patients With Urothelial Cancer (NCT00009867) | National Cancer Institute (NCI) | 2000-12-01 |
| Trastuzumab and Combination Chemotherapy in Treating Patients With Locally Recurrent or Metastatic Urinary Tract Cancer (NCT00005831) | National Cancer Institute (NCI) | 2000-03-01 |
| Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu (NCT00004074) | National Cancer Institute (NCI) | 1999-08-01 |